Not finding it? Sign in to also search OpenAlex live.
-
Lower Risk of Recurrence with a Higher Induction Dose of Mesalazine and Longer Duration of Treatment in Ulcerative Colitis: Results from the Dutch, Non-Interventional, IMPACT Study2022 Journal of Gastrointestinal and Liver Diseases article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Rachel Louise West, Maurice G. Rüssel, Alexander G L Bodelier, Johan P. Kuijvenhoven, Karlien F. Bruin, Jeroen M. Jansen, +12 more
11citations -
Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance2024 Breast Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Mieke Van Bockstal, Jelle Wesseling, Esther H. Lips, Marjolein L. Smidt, Christine Galant, Carolien H. M. van Deurzen
11citations -
Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study
Tijmen J.W.T. van der Wel, Mirjam C. Boelens, M. Jebbink, Sietske A. Smulders, Klaar W Maas, Merel J.A. Luitse, +7 more
11citations -
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial)2024 European Journal of Nuclear Medicine and Molecular Imaging article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Pim Hendriks, Daphne D. D. Rietbergen, Arian R. van Erkel, Minneke J. Coenraad, Mark J. Arntz, Roel J. Bennink, +18 more
9citations -
Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study2023 European Journal of Cancer article Medicine Cancer-related cognitive impairment studies Open access
Joosje C. Baltussen, Marloes G.M. Derks, Annelieke A. Lemij, Nienke A. de Glas, Marta F. Fiocco, E. Linthorst-Niers, +10 more
9citations -
Abstract GS2-11: Omission of sentinel lymph node biopsy in clinically T1-2 node-negative breast cancer patients treated with breast-conserving therapy: results of the Dutch BOOG 2013-08 randomized controlled trial after a median follow-up of 5 years2026 Clinical Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Robert‐Jan Schipper, Lori M. van Roozendaal, Veerle Marieke Wintraecken, Janine M. Simons, Martine Moossdorff, Ernest J. T. Luiten, +37 more
9citations -
Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Antitumor Activity of the Cyclin-Dependent Kinase-9 (CDK9) Inhibitor AZD4573 in Relapsed/Refractory Hematological Malignancies: A Phase 1 First-in-Human Study
Tim H. Brümmendorf, Patrick G. Medd, Raphael Koch, Stephan Stilgenbauer, Shringi Sharma, Yun He, +4 more
8citations -
Real‐world study on fluoropyrimidine‐related toxicity outcomes in cancer patients with select DPYD variant alleles that received DPYD genotype‐guided dosing2025 International Journal of Cancer article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Sofía L. J. Peeters, Didier Meulendijks, Zerina Kadric, Sara Ibrovic, Geert‐Jan Creemers, Vanja Milosevic, +7 more
7citations -
Disease extent according to baseline [18F]fluorodeoxyglucose PET/CT and molecular subtype: prediction of axillary treatment response after neoadjuvant systemic therapy for breast cancer2024 British journal of surgery article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Florien J G van Amstel, Cornelis Maarten de Mooij, Janine M. Simons, Cristina Mitea, P. J. van Diest, Patricia Joan Nelemans, +29 more
6citations -
A first-in-human study of DYP688, an antibody drug conjugate delivering a direct Gq/11 inhibitor, in patients with metastatic uveal melanoma (MUM) and other GNAQ/11 mutant melanomas.2025 Journal of Clinical Oncology conference-abstract Medicine Ocular Oncology and Treatments Open access
Matteo Salvatore Carlino, Reinhard Dummer, Tanja Gromke, Jessica Cecile Hassel, Ellen Kapiteijn, Damien Kee, +12 more
6citations -
AGO Breast Committee recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 20262026 European Journal of Surgical Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Maggie Banys‐Paluchowski, Christine Solbach, Thorsten Kühn, Volkmar Müller, Nina Ditsch, Tanja N. Fehm, +42 more
4citations -
Phase I trial to determine safety and immunogenicity of amplivant, a synthetic toll-like receptor 2 ligand, conjugated to two HPV16 E6 synthetic long peptides.2021 Journal of Clinical Oncology conference-abstract Immunology and Microbiology Immunotherapy and Immune Responses
Frank M. Speetjens, Marij J.P. Welters, Marije Slingerland, Peggy de Vos van Steenwijk, Inge C.F.M. Roozen, Sanne Boekestijn, +9 more
3citations -
The MARIANE-trial: Multicenter phase 1b/2 trial testing safety and efficacy of neoadjuvant intradermal ipilimumab and nivolumab in high-risk stage II melanoma.
Lotte L. Hoeijmakers, Anke M. J. Kuijpers, Bart A. van de Wiel, Marta López‐Yurda, Elsemieke I. Plasmeijer, Charlotte L. Zuur, +12 more
3citations -
Randomized Trial Comparing 5-Year Follow-Up of First-Line Infliximab to Conventional Therapy in Pediatric Crohn’s Disease2026 Clinical Gastroenterology and Hepatology article Medicine Inflammatory Bowel Disease Open access
Stephanie A. Vuijk, M Jongsma, Martinus A. Cozijnsen, Merel van Pieterson, Tim G. J. de Meij, Michael Groeneweg, +15 more
2citations -
A phase I/II study of eribulin mesilate (ERI) plus irinotecan (IRI) in children with refractory or recurrent solid tumors.2020 Journal of Clinical Oncology conference-abstract Medicine Cancer Treatment and Pharmacology Open access
Michela Casanova, Christof Maria Kramm, Dirk Reinhardt, Franco Locatelli, David R. D’Adamo, Yan Jia, +6 more
2citations -
Validation of minimal risk of recurrence classification by the Breast Cancer Index in early stage breast cancer2025 npj Breast Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Marie-France Jilderda, John M.S. Bartlett, Gerrit‐Jan Liefers, Y Zhang, Hywel Dunn-Davies, Valerie Rebattu, +12 more
2citations